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Abstract
Previous studies have shown that DNA can be transferred from dying engineered cells to neighboring cells through the
phagocytosis of apoptotic bodies, which leads to cellular transformation. Here, we provide evidence of an uptake of
apoptotic-derived cervical cancer cells by human mesenchymal cells. Interestingly, HeLa (HPV 18+) or Ca Ski (HPV16+) cells,
harboring integrated high-risk HPV DNA but not C-33 A cells (HPV-), were able to transform the recipient cells. Human
primary fibroblasts engulfed the apoptotic bodies effectively within 30 minutes after co-cultivation. This mechanism is
active and involves the actin cytoskeleton. In situ hybridization of transformed fibroblasts revealed the presence of HPV DNA
in the nucleus of a subset of phagocytosing cells. These cells expressed the HPV16/18 E6 gene, which contributes to the
disruption of the p53/p21 pathway, and the cells exhibited a tumorigenic phenotype, including an increased proliferation
rate, polyploidy and anchorage independence growth. Such horizontal transfer of viral oncogenes to surrounding cells that
lack receptors for HPV could facilitate the persistence of the virus, the main risk factor for cervical cancer development. This
process might contribute to HPV-associated disease progression in vivo.
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Introduction
Epidemiological and experimental studies have highlighted that
high-risk human papillomaviruses (HPV), especially HPV 16 and
18, play a major role in the induction of carcinomas of the cervix
[1,2]. The mechanistic aspects of HPV-induced carcinogenesis are
most often related to deletion of the E2 ORF as a consequence of
viral DNA integration into the host genome [3]. This leads to a
deregulated expression of viral E6 and E7 genes, which represent
the main transforming genes. At the heart of this transformation
are the binding of E6 to p53 and E6AP, which favors p53
degradation [4] and the E7 complex formation with the
retinoblastoma protein pRb [5], resulting in the deregulation of
cell cycle control, DNA repair and apoptosis.
During tumor development, a large percentage of cells is lost
through apoptosis [6]. Such cell death is triggered by a variety of
extracellular signals, including growth/survival factor depletion,
hypoxia and a loss of cell-matrix interactions, as well as
intracellular signals such as DNA damage [7]. Finally, apoptotic
cells are cleared by specialized phagocytic cells that inactivate and
degrade their cellular components [8]. However, apoptotic cells
can also be internalized by non-specialized recipient cells. Thus,
fibroblasts are able to engulf apoptotic neutrophils [9], and liver
endothelial cells can bind and phagocytose liver apoptotic bodies
[10]. Through this endocytic process, apoptotic cells can act as a
DNA vector, and the horizontally transferred DNA may confer a
selective advantage to the recipient cell.
Horizontal gene transfer (HGT) has been well documented in
prokaryotes and contributes to evolution, ecology and resistance to
antibiotics [reviewed in [11,12]]. While the horizontal transfer of
genetic information between two eukaryotes has been reported in
plants [13,14] and invertebrates [15], few studies have focused on
HGT between mammalian cells. The exchange of genetic
information mediated by apoptotic bodies has been shown to occur
between prostate cancer cells [16]. The apoptotic bodies of
transformed lymphoid cells harboring integrated copies of the
Epstein-Barr virus can also transfer viral DNA sequences [17].
Similarly, HIV-1 proviral genes are transferred to cells lacking
receptors for viral entry [18]. DNA has also been reported to be
transferred from apoptotic H-ras
V12- and c-myc-transfected cells to
p532/2 mouse embryonic fibroblasts, which leads to their
transformation [19]. On the other hand, phagocytosing cells that
express p53 or p21 are not transformed, suggesting a protective
mechanismcontrolledbythep53pathway[20].Recently,EhnforsJ.
et al. demonstrated that fibroblasts and endothelial cells are capable
of acquiring and replicating H-ras
V12 and c-myc DNA when
apoptotic tumor cells contain the simian virus 40 large T (SV40LT)
antigen [21]. These observations provided evidence that transfor-
mation efficiency is associated with the expression of SV40LT
inhibiting p53 [22]. Because the majority of cervical carcinomas
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36766express the E6 viral oncoprotein, which promotes p53 degradation,
as does SV40LT, we hypothesized that the horizontal transfer of
HPV oncogenes could be an alternative mechanism of carcinogen-
esis.
Here, we present evidence that apoptotic cells derived from
cervical-derivedcancercellsharboringintegratedcopiesofHPVare
able to transform human primary fibroblasts (HPF). We further
demonstrate that recipient tumor cells can be characterized by a
high rate of proliferation and hyperploidy. In addition, the viral
genetic material inhibiting the p53/p21 pathway is expressed in the
transformed cells. To our knowledge, this is the first report of the
transformation of human primary cells through the uptake of
apoptotic bodies from HPV-infected cervical carcinoma cells.
Results
Apoptotic cervical carcinoma cells are internalized by
fibroblasts
The apoptosis of cervical carcinoma donor cells was induced by
UVBirradiationandstaurosporineexposureaspreviouslydescribed
[23,24] and was documented by an analysis of phosphatidylserine
exposure (annexin V staining), DNA content (propidium iodide
staining) and nuclear fragmentation (DAPI staining) (Methods S1
and figure S1A and S1B). The treatment resulted in the absence of
living cells capable of proliferation within the apoptotic cell
suspensions (Methods S1 and figure S1C and SID). Previous studies
have shown that apoptotic bodies derived from EBV-carrying B
lymphocytes can transmit DNA by horizontal transfer and that
EBV-integrated DNA may be preferentially transferred as com-
pared with cellular DNA [17]. In this study, we questioned whether
HPFs could engulf apoptotic cells derived from the cervical
carcinoma cell lines HeLa (HPV18), Ca Ski (HPV16) and C-33 A
(HPV-), regardless of virological status.
The presence of fluorescent apoptotic cells in the recipient cells
was confirmed by confocal microscopy. Apoptotic HeLa cells
containing DNA were entangled in the actin cytoskeleton of the
HPFs within 48 h (figure 1A). Apoptotic Ca Ski and C-33 A cells
were also taken up efficiently by the recipient (figure 1B).
Incubation of the HPFs alone or with the supernatant of apoptotic
cells did not result in CFDA, SE (5-(and 6-)-carboxyfluoresceine
diacetate succinimidyl ester) staining, suggesting a link between
green fluorescence and the presence of apoptotic cells (figure 1B).
By tracking the fluorescent dyes at early time points (from 1 h to
3 h), we observed actin recruitment when apoptotic cells were
bound to HPFs (figure 1Ci, white arrow). The fibroblast
membrane expanded around both sides of the apoptotic cell
through actin polymerization (figure 1Cii, white arrows). F-actin
then surrounded the apoptotic cells to form a phagocytic cup and
closed in a ring (figure 1Ciii). These microscopic observations are
indicative of phagocytosis, although we have not specifically
characterized this mechanism [25,26]. Using specific markers of
intermediate filaments for each cell type, we confirmed that the
apoptotic cells were epithelial cells (cytokeratin positive) that were
internalized by fibroblasts (vimentin positive) (figure 1D). Using
the quantitative approach of flow cytometry, we assessed the
percentage of HPFs that engulfed the stained apoptotic carcinoma
cells. Regardless of the type of apoptotic cells used, the
internalization efficiency was similar (12.5% with apoptotic HeLa;
13% with apoptotic Ca Ski; 14.5% with apoptotic C-33 A)
(figure 1E). However, we noted that 12 to 15% of the fibroblasts
were able to take up the apoptotic cells, while the number of
apoptotic cells seeded was ten times larger than that of the HPFs.
This suggests that fibroblasts have a limited potential in the
efficiency and/or quantity of apoptotic cell internalization. When
recipient cells were co-incubated with apoptotic cells at 4uC for
48 h, the percentage of internalization dropped significantly to
2%, thus suggesting that the internalization process follows an
energy-dependent pathway (figure S2). These results indicate that
human primary fibroblasts can engulf apoptotic cells, independent
of their virological status, through phagocytosis.
Only HPV-positive apoptotic cells efficiently transform
recipient cells
Ehnfors et al. demonstrated that DNA from rat fibrosarcoma
apoptotic cells transfected with H-ras
V12,c - myc and SV40LT is
transferred to and transforms primary fibroblasts [21]. Because
HPV oncogenes, like SV40LT, are capable of efficiently trans-
forming infected cells and blocking the p53 pathway, among other
effects, we tested whether fibroblasts cultured with apoptotic cells
were able to grow with anchorage independence by measuring
their ability to form colonies in a soft agar assay, as observed with
the HeLa, Ca Ski and C-33 A cancer cells (figure 2A, upper line).
In contrast, human primary fibroblasts were unable to grow
without a solid matrix (figure 2A, upper line). Although the three
types of apoptotic bodies were internalized by fibroblasts, only the
apoptotic cells harboring HPV (HeLa and Ca Ski cells)
transformed the HPFs (figure 2A, middle line). The controls with
apoptotic cells alone did not result in colony formation (figure 2A,
lower line). These findings demonstrate that the incubation of
apoptotic cells with HPV-integrated DNA effectively induced
anchorage-independent growth of HPFs, a hallmark of transfor-
mation and an in vitro correlate of tumorigenicity in vivo [27]. The
transformation status of the HPFs was further tested by limit-
dilution assays. Indeed, in contrast to primary fibroblasts, the
fibroblasts transformed by apoptotic HeLa (FH) and Ca Ski (FC)
cells had the ability to form multilayer colonies when they were
grown at low density (figure 2B). At this stage, the FH and FC
began to exhibit a transformed phenotype, with some of the cells
appearing rounded, unlike the control HPFs, which displayed a
spindle shape (figure 2C). Moreover, the transformed fibroblasts
consisted mostly of packed or aggregated small cells such as HeLa
and Ca Ski cells, whereas the primary fibroblasts formed a
flattened monolayer.
Figure3Ashowsthattransformedfibroblasts,FCandFH,arenot
positive for cytokeratin staining, unlike epithelial HeLa and Ca Ski
cells, revoking the possibility that the observed transformed cells are
rare surviving cancer cells and a clonal evolution of Ca Ski cells. As
illustrated in the upper left panel of figure 3B (D18S61 marker, an
exampleof20markersofDNAtypingused),transformedfibroblasts
haveapatternofDNAthatisdifferentfromtheoriginaltumorcells.
OtherresultsofDNAtypingexperimentsshowedthatFCcellswere
differentfromCaSkicellsbutcontainsomeallelesfromCaSkiDNA
(TP53 and D8S264 markers), reflecting the transfer of small DNA
fragments. FC DNA also contains parts of chromosomes (D17S250
markers),reflectingthetransferoflargeDNAfragmentsasdescribed
by Holmgren [17,19]. Although these results demonstrate the
chromosomalrearrangement(lossandgainofalleles)ofFCcells,we
cannot exclude the possibility of cross-contamination, despite this
being highly unlikely.
Next, we determined the effects of HPF transformation on the
proliferationrateusingagrowthcurveandtheresultsfromtheMTT
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromid)pro-
liferation assay shown in Fig. 4A and 4B, respectively. The FH had
an average population doubling time of 15 h, and the FC had an
average time of 16 h, while the HPF doubling time was greater by a
factorof19(298 h)(figure4A).Themitochondrialactivitymeasured
by the MTT proliferation assay was concordant with the growth
curve results (figure 4B). These growth rate modifications support
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therefore tested whether the increased growth rate and the
transformation of the recipient cells were associated with genetic
modificationsleadingtohyperploidy.Cytometryassaysshowedthat
the DNA content increased with the passages of transformed
fibroblasts (figure 4C). In our experiments, an HPF mean
fluorescence intensity (MFI) of 154 corresponded to diploid cells
(figure 4D). The MFI increased to 205 and 250 after 5 (P5) and 15
(P15) passages of FH cells, respectively. We observed similar results
fortheFCcells(219atP5and264atP15).TheMFIatpassages15of
FH and FC represented hypertriploidy. Aneuploidy, as seen in our
model,isoftencausedbyaparticulartypeofgeneticinstabilityandis
one of the most common properties of cancers [28].
Apoptotic HPV-associated cancer cells efficiently transfer
viral oncogenes to fibroblasts
Because only apoptotic HeLa and Ca Ski donor cells were able
to transform fibroblasts, we hypothesized that HPV oncogenes
could be transferred to the recipient cells. Our confocal
microscopy analysis suggested that genetic material was trans-
ferred from the apoptotic cells to the fibroblast nuclei after 6 h of
co-culture (figure 5A, white arrows). The actin cytoskeleton
reorganization appeared to deliver the apoptotic cell toward the
nucleus for DNA transfer, as seen at a high magnification by
superimposing transmitted light with phalloidin or DAPI staining
images. Following these observations, we investigated the HPV
DNA transfer in fibroblast recipients using in situ hybridization
(ISH) with a probe hybridized specifically to high-risk HPV DNA.
HeLa and Ca Ski cells were used as positive controls. Confirming
our hypothesis, the hybridization signals were observed as purple
dots in the apoptotic cells and nuclei of the transformed fibroblasts
(FH and FC) whereas no signal was detected in the HPFs
(figure 5B). These data validate the hypothesis of horizontal
transfer of viral oncogenes. A second approach consisting of
amplifying the E6 DNA of HPV 16 and 18 confirmed the presence
of viral DNA in the transformed fibroblasts (figure 5C). We further
analyzed the expression of E6 HPV16 and E6 HPV18 by reverse
transcriptase followed by real-time quantitative PCR. Figure 6A
illustrates that the E6 transcripts were detected in the transformed
FH and FC cells with however lower levels than in the parental
HeLa and CaSki cells. These data suggest that the transfer of viral
oncogenes is efficient and functional. To more thoroughly
scrutinize the role of the transferred E6 oncogenes as inhibitors
of p53 expression, we immunoblotted for p53 and one of its
targets, p21. Accordingly, the p53 and p21 levels of the
transformed HPFs decreased substantially, similar to the decrease
in donor cancer cells (figure 6B). Overall, these results emphasize a
critical role of viral oncogene transfer in the transformation of
primary cells, a process that bypasses the p53 pathway.
Discussion
The results of this study provide direct evidence of the
oncogenic potential of HPV positive apoptotic cells. The transfer
of viral DNA derived from HPV-positive cervical cancer cells
through HGT promoted the growth and transformation of HPFs
and could represent an alternative mechanism for HPV-associated
Figure 1. Apoptotic cells are engulfed by fibroblasts. (A) Co-culture of HPFs and apoptotic HeLa cells. (B) HPFs co-cultured with apoptotic Ca
Ski cells (upper left), apoptotic C-33 A cells (upper right), alone (bottom left) and the supernatant of apoptotic HeLa cells (bottom right). (C) HPFs
were cultured with apoptotic HeLa cells for different lengths of time: 1 h (Ci), 2 h (Cii) and 3 h (Ciii). The pictures show actin recruitment and
membrane expansion formation (arrows). (D) HPFs, Ca Ski cells and HPFs plus apoptotic Ca Ski or HeLa cells were stained with anti-vimentin (TRITC)
and anti-cytokeratin (Cy2) antibodies. Microscope observations were performed with a confocal microscope (scale bar: 1 mm). All results are
representative of four independent experiments. (E) HPFs were incubated with apoptotic HeLa, Ca Ski or C-33 A cells for 48 h and apoptotic cell
internalization was quantified by flow cytometry.
doi:10.1371/journal.pone.0036766.g001
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horizontal oncogene transfer between eukaryotic cells [19]. In
their model, the donor cells were primary rodent fibroblasts
modified to overexpress c-myc and H-ras
V12 and a hygromycin-
resistant gene that permitted a highly stringent selection of
transformed recipient cells after HGT.
In our study, the internalization rates of apoptotic cancer cells
were similar, regardless of the HPV status. However, the finding
that only HeLa and Ca Ski cancer cells carrying naturally
integrated HPV oncogenes, but not HPV-negative C-33 A cells
are able to transform phagocytosing fibroblasts provides support
for the hypothesis that viral DNA transferred by apoptotic cells
can be reused and expressed by recipient cells.
The in vitro recipient cell transformation by horizontally
transferred DNA, facilitated by DNA fragmentation, was shown
to be dependent on p53 [29]. Indeed, p53- or p21-deficient cells,
but not wild-type p53 fibroblasts, became tumor-like after their
uptake of c-myc and H-ras
V12 oncogenes, indicating that the Chk2/
p53/p21 signaling pathway protects cells against the propagation
of potentially harmful DNA [19,20,30]. Moreover, SV40LT,
which facilitates p53 degradation, can overcome this genetic
surveillance both in vitro and in vivo [21]. Like SV40LT, the E6
oncoproteins of HPV type 16 and 18 are physically associated with
wild-type p53 and favor its proteosomal degradation [reviewed in
[31]]. An analysis of the transformed fibroblasts revealed that they
contained E6 HPV16 or E6 HPV18 DNA. In addition, ISH
showed that HPV DNA from the apoptotic cancer cells was
transferred into the nuclei of recipient fibroblasts. Once the DNA
was transferred, the expression of HPV E6 genes was detected at
the RNA level up to 15 weeks after the start of co-culture
experiments. The E6-expressing recipient cells exhibited decreased
levels of p53 as well as its target, p21, which might partly explain
the alterations in growth control circuitry.
We intended to confirm by genotyping that transformed
fibroblasts were unique and were derived from primary fibroblasts
andparentalcancercelllines.Bystudyingseveralmicrosatellites,we
found that they actually harbored some alleles identical to those
identifiedinapoptoticcervicalcancercells.However,duetotheloss
Figure 2. Apoptotic cells infected by HPV transform fibroblasts. (A) HPFs and HeLa, Ca Ski and C-33 A cervical cancer cells (upper line); HPFs
after 48 h of exposure to apoptotic cells (apo HPF, apo HeLa, apo Ca Ski, apo C-33 A) (middle line) were cultured in soft agar for 21 days. Apoptotic
cells alone were also cultured as a control (lower line). Photographs were taken with a 206magnification lens. (B and C) HPFs, HeLa cells, Ca Ski cells
and transformed fibroblasts by apoptotic HeLa (FH) and apoptotic Ca Ski (FC) cells (after selection on soft-agar), were grown at a limit-dilution for 21
days. (B) The colonies stained with purple crystal were counted, and the plating efficiency (PE, percentage of cells able to form colonies; SD, standard
deviation) was calculated. (C) Colony magnifications were photographed with a 406magnification lens.
doi:10.1371/journal.pone.0036766.g002
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they were derived from primary fibroblasts. We cannot therefore
completely exclude the possibility of cross-contamination with an
unrelated cell line, even if this possibility appears improbable.
However, virally altered fibroblasts that were able to form colonies
demonstrated peculiar morphological characteristics, a high prolif-
eration rate and aneuploidy. The transition from diploidy to
aneuploidy, a hallmark observed in virtually all cancers [28], has
Figure 3. Cytokeratin expression and DNA profiles of transformed fibroblasts differ from the parental cancer cells. (A) HPFs, Ca Ski,
HeLa, FC and FH cells were analyzed by immunocytofluorescence for cytokeratine expression (scale bar: 1 mm). (B) DNA from Ca Ski and FC cells was
amplified by fluorescent PCR using 20 microsatellites. Four representative microsatellite amplifications are shown. Different types of allele are
observed using four markers: D18S61 TP53, D8S264 and D17S250.
doi:10.1371/journal.pone.0036766.g003
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[32] and has been attributed to the synergistic effect of E6 and E7
oncoproteins [reviewed in [31]]. However, high-risk HPV immor-
talized cells are non-tumorigenic, and the activation of cellular
oncogenesc-myc,H-rasandc-fosisnecessarytocompletelyovercome
the anti-oncogenic function of p53 and to result in cervical cancer
development [33,34,35]. Further study of the expression of these
possibly activated cellular oncogenes will aid in understanding the
mechanism of fibroblast transformation. Nonetheless, HPV onco-
gene transmission could have a role more crucial than considered,
since the expression of HPV16 E6 oncogene in HPV negative C-33
A cells confers an aggressive phenotype as shown by the radiation
resistance in transplanted tumors [36].
Escapefromimmunesurveillancemechanismsmayrepresentthe
main risk factor for HPV DNA persistence and lesion progression,
whereastheviraltransferfromapoptoticbodiestosurroundingcells
lacking receptors for HPV in vivo could facilitate the persistence of
HPVinthecervix.Moreover,suchtransfermightexplainthespread
of HPV to mesenchymal cells, as observed by ISH in cervical
carcinomas [37,38], and the possibility of a stromal reservoir for
HPV. Furthermore, in human solid tumors, a subset of cancer cells,
called cancer stem cells, that are likely initiated as a result of HGT
cause very aggressive cancers with a high propensity toward
metastatic dissemination [39]. This might explain the positive
association between the rate of intratumoral apoptosis and several
cervical tumor parameters such as tumor size, lesion grade,
metastatic phenotype and patient survival [7,40,41,42].
In addition, the increased prevalence of apoptotic cells following
chemo- and/or radiation therapy could be partly responsible for
the recurrence of HPV lesions by inducing the transformation of
new cells at the same or different anatomic locations months or
years after remission [43,44]. Investigations of this possibility are
warranted, in addition to efforts to find new therapeutic strategies
targeting E6/E7 oncogenes to limit their horizontal transfer and to
control tumor development.
Materials and Methods
Cell culture and apoptosis induction
HPFs were isolated from adult human skin after abdomino-
plasty as previously described [45] and were grown in complete
DMEM (Lonza) containing 10% FBS (Lonza), penicillin/strepto-
mycin and L-glutamine. HPFs extracted from surgical residues are
not subject to validation from an ethics committee and the
patient’s consent in accordance with the law L.1245-2 of the
Figure 4. Transformed fibroblasts acquire tumorigenic characteristics. (A and B) HPFs and HPFs transformed by apoptotic HeLa (FH) or
apoptotic Ca Ski (FC) cells were grown for the indicated lengths of time. The cell proliferation was monitored each day by counting the total numbers
of cells (A) and by MTT assays (B). The graphs present the mean (+/2 SD) of three independent experiments. (C) HPFs, FH and FC at passages 5 (P5)
and 15 (P15) were stained (10
6 cells) with propidium iodide solution, and analyzed by flow cytometry. (D) The MFI of the G0/G1 peak (mean of three
independent experiments +/2 SD) displays the ploidy of HPF, FH and FC at P5 and FH and FC at P15.
doi:10.1371/journal.pone.0036766.g004
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laboratory of skin engineering of Prof. Philippe Humbert’s
dermatology departement, providing human fibroblasts, has
manuscript documents stating the patient’s non-opposition to the
use of his surgical residues to medical research in accordance with
the law L.1211-2. Human cervical carcinoma cell lines (ATCC),
HeLa (HPV18, wild-type p53) and C-33 A (HPV negative,
mutated p53) were grown in complete EMEM (Lonza), and Ca Ski
cells (HPV16, wild-type p53) were grown in complete RPMI
(Lonza). They were monitored monthly and found to be free of
mycoplasms. Twelve hours prior to apoptosis induction, the
carcinoma cells were seeded at 2610
4 cells/cm
2. They were then
treated with 20 mJ/cm
2 UVB irradiation followed by 300 nM
staurosporine (STS) (Sigma Aldrich) for 48 h. The apoptotic cells
were harvested after centrifugation of the supernatant at 300 g for
10 min. The apoptosis detection was conducted as described in the
supplemental information (Methods S1). The apoptotic cells were
incubated with HPFs at a ratio of 10:1. This ratio was chosen
because a higher ratio causes fibroblast death and a lower ratio
decreases the rate of internalization.
Apoptotic cell internalization analysis
The apoptotic cells were stained with 1 mg/ml CFDA, SE
(Invitrogen Ltd) diluted in DMEM with 2% FBS for 13 min at
37uC. After washing, they were incubated for 48 h with recipient
cells. For cytometry analysis, the fibroblasts incubated with the
Figure 5. HPV oncogenes are transferred through apoptotic cells to transformed fibroblasts. (A) The images illustrate the DNA transfer
from the apoptotic cells to the fibroblast recipients (arrows). Microscopic observations were performed with a confocal microscope (scale bar: 1 mm).
(B) High-risk HPV DNA was detected by in situ hybridization in parental and apoptotic HeLa and Ca Ski cells, FH and FC but not in HPFs. Cells were
counterstained with eosin (scale bar: 1 mm). (C) Agarose gel electrophoresis of amplified human albumin and E6 HPV18 and E6 HPV16 DNA (MW:
molecular weight). The images are representative of three independent experiments.
doi:10.1371/journal.pone.0036766.g005
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using a Cell Lab Quanta
TM SC flow cytometer (Beckman
Coulter). Apoptotic cells were labeled with CFDA, SE and HPFs
were distinguished from apoptotic cells by their diameter as
evaluated by flow cytometry. Events with small diameters
(,13 mm) and positive for CFDA SE, were considered apoptotic
cells;, events with large diameters (.13 mm) and negative for
CFDA, SE, were HPFs, and events with large diameters and
positive for CFDA, SE, were HPFs with engulfed apoptotic cells.
For confocal microscopy, fibroblasts grown on coverslides were
fixed with 3.7% paraformaldehyde for 20 min at 4uC and
permeabilized using 0.1% triton X100 for 10 min at room
temperature (RT). The cells were stained using TRITC (tetra-
methylrhodamine-isothiocyanate)-conjugated phalloidin (Sigma
Aldrich) for 30 min at 4uC and with 300 nM 49,6-diamidino-2-
phenylindole, dihydrochloride (DAPI; Invitrogen) for 5 min at
RT. The 3D picture (z projection) was reconstituted from 32
horizontal 2D slices obtained by confocal microscopy. Another set
of cells was incubated with two primary antibodies: a monoclonal
mouse anti-human cytokeratin antibody (clone AE1/AE3, Dako-
cytomation) used at 1:50 and a monoclonal rabbit anti-human
vimentin antibody (clone SP20; GeneTex) used at 1:100 dilution.
Corresponding secondary antibodies (Jackson ImmunoResearch)
coupled to cyanine 2 (CY
TM2-conjugated AffiniPure Goat anti-
Mouse IgG) or to rhodamine (Rhodamine (TRITC)-conjugated
AffiniPure Donkey Anti-Rabbit IgG) were used at 1:50 dilution.
The coverslides were finally examined by using an Olympus
FluoView 1000 fluorescence microscope (Olympus).
Colony formation assay, cell growth and aneuploidy
analysis
Soft agar assays were conducted in 24-well plates in semi-solid
media (DMEM, 10% FBS, 0.35% agar; Invitrogen) with 8610
3
and 3610
5 cells/ml on a media base layer (RPMI, 10% FBS,
0.5% agar). The cells were grown for 21 days, and the colonies
were observed using an Axiovert 25 inverted microscope (Zeiss)
[27]. The colonies were then harvested by scraping the surface of
the soft-agar and two cell lines of fibroblasts transformed by
apoptotic HeLa (FH) and Ca Ski (FC) cells were derived and used
for further experiments.
Primary fibroblast transformation was also tested by limit-
dilution cultures in 6-well plates at 5610
2 cells/well for 21 days.
The colonies were then stained using a purple crystal solution
(0.1% purple crystal (w/v), ethanol 5%) and photographed with a
Nikon Coolpix 4500 digital camera (Nikon) [46].
The proliferation of the transformed cells was monitored by
countingthetotalnumberofcellsineachindividualwelldailyfor10
days with a Cell Lab Quanta
TM SC flow cytometer. The
proliferation was also monitored using the MTT test with the Cell
Proliferation Kit I (MTT) (Roche) for 5 consecutive days. The
formation of purple formazan crystals was quantified using the
scanning multi-well spectrofluorimeter EnVisionH 2102 Multilabel
Reader (Perkin Elmer). For the aneuploidy analysis, 10
6 living cells
were collected and fixed overnight in 70% (v/v) cold ethanol. After
two washes, the cells were stained with a propidium iodide solution
(0.1 mg/ml propidium iodide, Sigma Aldrich; 20 mg/ml RNaseA
DNase-free, ABgene). After 15 min at RT, 20,000 events were
analyzed by an FC500 flow cytometer (Beckman Coulter). The
meanfluorescenceintensity(MFI)oftheG0/G1peakwasevaluated
using the CXP
TM cytometer software and expressed in arbitrary
units.
In situ hybridization
Cells were cultured overnight on poly-L-lysine microscope slides
(Thermo Fisher Scientific), fixed with 3.7% paraformaldehyde for
15 min at RT and permeabilized with PBS Tween 1% for 10 min
at RT. The high-risk HPV DNA detection was conducted using
the INFORMH HPV family probe (Ventana Medical Systems) and
the BenchMarkH XT Automated Slide Stainer (Ventana Medical
Systems) as described by the manufacturer. The cells were also
counterstained with eosin.
Amplification of microsatellites and viral genes
Total DNA was extracted from 10
6 cells using the QIAampH
DNA Mini Kit (Qiagen, Courtaboeuf, France). For typing,
extracted DNA was amplified by fluorescent PCR as described
previously [47]. A panel of 20 microsatellites was used. Primers
were obtained from the Genome Data Base (www.gdb.org) or
Genemap’99 (www.ncbi.nlm.nih.gov/genemap99/). Amplified
fragments were analyzed on an ALF Sequencer (Amersham-
PharmaciaH, Piscataway, NJ, US), allowing for a very sensitive and
quantitative evaluation of the allele ratio by measuring the peak
height of both alleles.
For viral gene detection, PCRs targeted the albumin, E6 HPV16
and E6 HPV18 genes, using 500 nM of the corresponding primers
(Eurogentec, Seraing, Belgium). The sequences of the albumin and
E6 HPV16 primers have been previously described by Laurendeau
Figure 6. Downregulation of p53 in transformed fibroblasts
expressing E6 HPV transcripts. (A) E6 HPV18 and E6 HPV16 RNA
quantification from HPFs, parental cells and fibroblasts transformed by
apoptotic HeLa cells or apoptotic Ca Ski cells (named FH and FC
respectively) was performed by real-time quantitative PCR following
reverse transcription. The graphs represent the mean of three
independent experiments (+/2 SD). (B) Immunoblotting analyses of
p53 and p21 expression in cancer cell lines, HPFs and FH and FC
transformed fibroblasts, using mouse monoclonal antibodies against
p53 and p21. Blots were also probed with a b-actin antibody.
doi:10.1371/journal.pone.0036766.g006
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HPV18 primers are patent pending [48,49]. After a hot-started
reaction at 94uC for 5 min, the target DNAs were amplified for 30
cyclesfor30 secat94uC,30 secattheannealingtemperature(57uC
for albumin, 51uC for E6 HPV16 and 55uC for E6 HPV18) and
20 sec at 72uC, followed by a 7-min extension at 72uC. The PCR
products were analyzed by agarose gel electrophoresis.
Detection of viral transcripts
Total RNA was extracted from 2610
6 cells using the QIAampH
RNA Blood Mini Kit (Qiagen). After DNAse I treatment
(Invitrogen), the reverse transcription of 500 ng of RNA was
performed using the MMLV-Reverse Transcriptase (Invitrogen).
Twenty five nanograms of cDNA were pre-amplified using 45 nM
E6 HPV16, E6 HPV18 and human b-2-microglobulin primers in
the TaqMan PreAmp Master Mix (Applied Biosystems) as follows:
a 10-min step at 95uC and 10 amplification cycles (15 sec at 95uC,
4 min at 60uC). The quantification of the pre-amplified products
was performed with a 7500 Real Time PCR System (Applied
Biosystems) in the TaqMan Gene Expression Master Mix (Applied
Biosystems), using 500 nM of each primer (Eurogentec) and
TaqMan Probes (100 nM for b-2-microglobulin: 59FAM-cctccat-
gatgctgcttacatgtctcgatccc-BHQ1-39; 250 nM for E6 HPV16: 59-
FAM-aggagcgacccagaaagttaccacagtt-BHQ1-39 or E6 HPV18: 59-
JOE-caacacggcgaccctacaagctacc-BHQ1-39, Eurogentec) accord-
ing to the manufacturer’s thermal cycling protocol. Standard
curves were obtained by serial dilutions over a range of six log
concentrations of the pBR322-HPV16 and pBR322-HPV18
diluted in 50 ng/ml salmon sperm DNA.
Immunoblotting
Immunoblotting was performed as described previously [50].
Briefly, 30 mg of protein was separated by SDS-PAGE and
electrotransferred onto Hybond
TM-P membranes (GE Healthcare
Lifesciences). Mouse monoclonal antibodies against p53 (clone
DO-7, Becton Dickinson), p21 (clone 6B6, Becton Dickinson) and
b-actin (clone AC-15, Sigma Aldrich) were used at 1:500, 1:500
and 1:8000 dilutions, respectively. A secondary antibody coupled
with alkaline phosphatase was used at 1:10000 for p53, 1:5000 for
p21 and 1:40000 for b-actin. The immunoblots were analyzed by
chemiluminescence using the ECL Plus Reagents System (GE
Healthcare Wauwatosa).
Supporting Information
Figure S1 UVB and staurosporine treatments of HeLa,
Ca Ski and C-33 A cells induce the formation of
apoptotic body suspensions devoid of living cells. HeLa,
Ca Ski and C-33 A cells were treated with UVB irradiation at
20 mJ/cm
2 (UV 20) and/or 300 nM staurosporine (STS) for 48 h.
The cells and apoptotic body suspension were harvested and
characterized. Ai, Phosphatidylserine exposure was evaluated by
flow cytometry after annexin V-FITC labeling. Aii, The DNA
content was quantified using propidium iodide staining. (A)
Cumulative data of four independent experiments (upper panel)
and representative data of flow cytometry analysis (lower panel).
(B) Nuclear fragmentation was observed by fluorescent microscopy
after DAPI staining. The proliferation of the cells and apoptotic
body suspensions was verified by MTT (C) and by culture from 7
to 28 days (D). For each panel, four independent experiments were
performed yielding similar results.
(TIF)
Figure S2 Apoptotic cell engulfment involves an energy-
dependent pathway. HPFs were incubated with apoptotic
HeLa (Apo HeLa), Ca Ski (Apo Ca Ski) or C-33 A (Apo C-33 A)
cells for 48 h at 37uC and 4uC. Apoptotic cells were labeled with
CFDA, SE, prior to incubation. HPFs were distinguished from
apoptotic cells by their diameter as evaluated by cytometry (. or
,13 mm). Events with small diameters and positive for CFDA, SE,
were considered apoptotic cells (upper left quadrant), events with
large diameters and negative for CFDA, SE, were HPFs (bottom
right quadrant), and events with large diameters and positive for
CFDA, SE, were HPFs with engulfed apoptotic cells (upper right
quadrant). The results are representative of three independent
experiments.
(TIF)
Methods S1
(DOC)
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